Dual Antiplatelet Therapy

Cardiology app to decide dual antiplatelet therapy after coronary stent surgery

This "Dual Antiplatelet Therapy - Cardiovascular Risk" app will calculate the dual antiplatelet therapy (DAPT) score for every patient based on clinical and demographic characteristics. In patients with high risk score should be advised to get prolonged dual antiplatelet therapy (DAPT) after coronary stent placement. The question of stopping dual antiplatelet therapy (DAPT) is an important everyday problem for many clinicians. This "Dual Antiplatelet Therapy - Cardiovascular Risk" app is intended to help medical practitioner, especially in cardiology department to assess their patients.

There are several features of "Dual Antiplatelet Therapy - Cardiovascular Risk", namely:

🔸 Simple and very easy to use.

🔸 Precise calculation with dual antiplatelet therapy score.

🔸 Decide who should get prolonged dual antiplatelet therapy after coronary stent surgery.

🔸 It is totally free. Download now!

The implantation of coronary stents has become a standard treatment for the management of patients with coronary artery disease, or commonly known as heart attack. Dual antiplatelet therapy (DAPT) is the cornerstone of pharmacological treatment aimed at preventing the atherothrombotic complications after coronary stent placement. Current clinical guidelines recommend at least 6- to 12-month treatment, but a longer duration of dual antiplatelet therapy (DAPT) may be beneficial in some patients. Download "Dual Antiplatelet Therapy - Cardiovascular Risk" app now!